Omnitrope®
ACTIVE PRINCIPLE:
Somatotropin
INDICATION:
Dwarfism
Prader-Willi syndrome
Turner syndrome
DATE:
06/07/2006
STATUS:
Authorized
Biosimilar medicine authorized by the AEMPS
ACTIVE PRINCIPLE:
Somatotropin
INDICATION:
Dwarfism
Prader-Willi syndrome
Turner syndrome
DATE:
06/07/2006
STATUS:
Authorized
Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.